Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, April 2017, Vol 298, No 7900

Sort by: Newest first Oldest first A-Z Z-A

  • Deaths: Fiona Campbell Lyons Subscription

    31 MAR 2017 14:57

    On 12 January 2017, Fiona Campbell Lyons MRPharmS, aged 53, of Boscombe, Bournemouth. Mrs Campbell registered with the Society in 2005.

  • Deaths: Ramon Dalal Subscription

    31 MAR 2017 14:57

    On 24 March 2017, Ramon Dalal MRPharmS, aged 85, of Cheadle Hulme, Cheshire. Mr Dalal registered with the Society in 1957.

  • Deaths: Victor James Kapur Subscription

    31 MAR 2017 14:52

    On 24 March 2017, Victor James Kapur, of Wellingborough, Northamptonshire. Mr Kapur registered with the Society in 1955 and left in 2006.

  • Sunscreen should not be seen as a beauty product Subscription

    31 MAR 2017 11:08 By Gillian Nuttal

    Melanoma UK is deeply concerned about NHS England’s plans to remove a number of medicines from being prescribable which they deem ‘low priority’ (The Pharmaceutical Journal online, 29 March 2017). The suggestion that sunscreen has “little clinical value” is ...

  • Patient in a wheelchair

    FDA approves first drug for progressive multiple sclerosis

    31 MAR 2017 9:17

    The US Food and Drug Administration (FDA), which is responsible for evaluating the safety and efficacy of medicines in the United States, has approved the use of ocrelizumab (Ocrevus; Genentech) for adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS).

  • Atopic dermatitis

    FDA approves first monoclonal antibody injection for atopic dermatitis

    30 MAR 2017 10:00

    The US Food and Drug Administration (FDA), which is responsible for evaluating the safety and efficacy of medicines in the United States, has approved the use of dupilumab (Dupixent; Regeneron Pharmaceuticals) to treat adults with atopic dermatitis.

  • Shelves of gluten, dairy and nut free food on shelves in a Tesco store

    NHS England to issue guidance on dropping ‘low priority’ drugs from NHS prescriptions

    29 MAR 2017 10:36 By Debbie Andalo
    Comments (2)

    NHS England has identified a number of medicines that should no longer be available on prescription in a move that would save the NHS £128m a year.

  • Qualified Person: Anne Radmall Subscription

    29 MAR 2017 10:00

    Anne Radmall MRPharmS, lead quality adviser, AstraZeneca, was added to the Royal Pharmaceutical Society’s Qualified Person (QP) register on 28 March 2017. Having successfully passed the Joint Professional Bodies’ QP viva, she is eligible to be named as a QP on manufacturers’ authorisations.

  • Pfizer's product information leaflet for sildenafil citrate, more commonly known under brand name Viagra

    MHRA recommends that sildenafil is made available over the counter in the UK

    28 MAR 2017 16:14 By Debbie Andalo
    Comments (1)

    Sildenafil — the prescription-only medicine branded as Viagra for the treatment of erectile dysfunction — could become a pharmacy (P) medicine if government proposals go ahead.

  • European Medicines Agency building, Canary Wharf

    EMA calls for suspension of generic drugs after concerns about quality of data

    28 MAR 2017 11:45

    A list of generic drugs — including 41 that are available in the UK — have been recommended for suspension across the EU because of doubts over the quality of the bioequivalence data used to grant their national marketing authorisation. 

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.